إعلان
إعلان
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
105.00
USDبرعاية
-2.05
-1.91%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
110.00
+5.00
+4.77%
تقارير أرباح RYTM
النسبة الإيجابية المفاجئة
RYTM تفوق 17 من 33 آخر التقديرات.
52%
التقرير التالي
بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$56.12M
/-$0.83
التغير الضمني من Q3 25 (Revenue/ EPS)
+9.40%
/+1.22%
التغير الضمني من Q4 24 (Revenue/ EPS)
+34.16%
/+15.28%
Rhythm Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, RYTM reported earnings of -0.82 USD per share (EPS) for Q3 25, missing the estimate of -0.73 USD, resulting in a -11.05% surprise. Revenue reached 51.30 مليون, compared to an expected 51.72 مليون, with a -0.81% difference. The market reacted with a -7.69% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analysts forecast an EPS of -0.83 USD, with revenue projected to reach 56.12 مليون USD, implying an increase of 1.22% EPS, and increase of 9.40% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Rhythm Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Rhythm Pharmaceuticals, Inc. Common Stock reported EPS of -$0.82, missing estimates by -11.05%, and revenue of $51.30M, -0.81% below expectations.
How did the market react to Rhythm Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -7.69%, changed from $113.74 before the earnings release to $104.99 the day after.
When is Rhythm Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
What are the forecasts for Rhythm Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 17
analysts, Rhythm Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.83 and revenue of $56.12M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان